Ocuphire Pharma, Inc.
Clinical trials sponsored by Ocuphire Pharma, Inc., explained in plain language.
Ocuphire Pharma, Inc.
OCUP
NASDAQ
Ophthalmology company developing therapies for retinal and refractive eye conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.